ReviewAngewandte Chemie (International ed. in English)2026
Promiscuity-Guided Enzyme Evolution via Substrate Multiplexed Screening.
Review in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
An enzyme's ability to react with diverse substrates while maintaining high yield and selectivity, termed "substrate promiscuity," is a highly sought-after property in biocatalysts. Traditional directed evolution typically relies on single-substrate screening, which enables adaptive evolutionary pathways but provides limited information on promiscuity. This approach can inadvertently narrow substrate scope, and it is often unclear whether alternative mutational paths might have facilitated broader reactivity. Here, we review substrate multiplexed screening (SUMS), a strategy that places substrates in direct competition and quantifies multiple products simultaneously. When enzymes operate in competitive environments, such as living cells or multi-enzyme cascades, SUMS directly mirrors the intended use. We discuss how SUMS generates promiscuity information that can guide engineering, even when the final application involves individual substrates. Examples illustrate how SUMS can increase information density relative to parallel screening and, in select cases, reveal activity shifts that are invisible to single-substrate methods. We discuss the strengths and limitations of SUMS and highlight instances where its application led to enzymes with broad or complementary scopes, identified allosteric mutations, or enabled the circumvention of negative epistasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.